Partnership for Safe Medicines statement on FDA authorization of Colorado’s Section 804 Importation Program

“Colorado is now poised to repeat Florida’s failed attempt to implement Canadian drug importation,” said PSM Executive Director Shabbir Imber Safdar. “Since beginning their program in 2019, Florida has spent $132 million and still not imported a single unit of medicine, proving that these bulk importation programs are not reducing drug costs for Americans.”

[...]

Prescription Drug Freight Fraud, June 2026 report

March and April 2026 saw thousands of shipments of drugs imported into the US, including weight loss drugs and antibiotics. We studied these shipments to learn more about their manufacturers and contents.

[...]

The FDA speaks up about AFPs and drug importation

Is personal drug importation legal in the context of alternative funding programs? The FDA says no.

Are self-funded health plans allowed to import medicine because of “Section 804” or “Florida’s importation plan”? Also, no.

[...]

Prescription Drug Freight Fraud Report, January 2026

The last two months of 2025 saw thousands of shipments of drugs popularized by social media imported into the U.S., as well as Xarelto and antibiotics. The shipments carried a wide range of product codes; some appropriate, and others far less so.

[...]

Prescription Drug Freight Fraud Report, September 2025

Our analysis of data from June and July revealed hundreds of pharmaceutical shipments that entered the U.S. from facilities no one would expect, including unregistered Chinese exporters and alternative medicine clinics abroad.

[...]

Prescription Drug Freight Fraud Report, July 2025

What if your tirzepatide shipment came from a Brazilian beauty clinic? Or a vial of semaglutide was manufactured, supposedly, at a Costco in Toronto? In April and May 2025, dozens of shipments of semaglutide, tirzepatide, apixaban, and antibiotics entered the U.S. from facilities that aren’t in the FDA’s drug manufacturing database. These aren’t low-volume personal-use…

[...]